Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: A preliminary study

Cornea

Volumn 15, Issue 4, 1996, Pages 368-372

  Fujishima, Hiroshi ^a,b   Shimazaki, Jun ^a   Yagi, Yukiko ^a   Tsubota, Kazuo ^a,b  

^a TOKYO DENTAL COLLEGE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aldose reductase inhibitor; Corneal sensation; Tear break up time; Tear dynamics

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; EPALRESTAT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORNEA EPITHELIUM; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMAN; LACRIMAL FLUID; LACRIMATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; AGED; ALDEHYDE REDUCTASE; CORNEA; CORNEAL DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; RHODANINE; SENSATION; TEARS; THIAZOLIDINES;

EID: 0029951568     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199607000-00006     Document Type: Article

References (34)

1. Brightbill FS, Myers FL, Bresnick GH. Postvitrectomy keratopathy. Am J Ophthalmol 1987;85:651-5.
2. Perry HD, Foulks GN, Thoft RA, Tolentino FI. Corneal complications after closed vitrectomy through the pars plana. Arch Ophthalmol 1978;96:1401-3.
3. Michels RG, Ryan SJ Jr. Results and complications of 100 consecutive cases of pars plana vitrectomy. Am J Ophthalmol 1975;80:24-9.
4. Schultz RO, Matsuda M, Yee RW, Edelhauser HF. Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol 1984;98:401-10.
5. Schultz RO, Horn DLV, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc 1981;79:180-99.
6. Schwartz DE. Corneal sensitivity in diabetics. Arch Ophthalmol 1974;91:174-8.
7. Snip RC, Thoft RA, Tolentino FI. Similar epithelial healing rates of the corneas of diabetic and nondiabetic patients. Am J Ophthalmol 1980;90:463-8.
8. Tsubota K, Chiba K, Shimazaki J. Corneal epithelium in diabetic patients. Cornea 1991;10:156-60.
9. Foulks GN, Thoft RA, Perry HD, Tolentino FI. Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol 1979;97:1076-8.
10. Hyndiuk RA, Kazarian EL, Schultz RO, Seiderman S. Neurotrophic corneal ulcers in diabetes mellitus. Arch Ophthalmol 1977;95:2193-6.
11. Kinoshita JH, Fukushi S, Kador P, Merola LO. Aldose reductase in diabetic complications of the eye. Metabolism 1979;28:462-9.
12. Cogan DG, Kinoshita JH, Kador PF, et al. Aldose reductase and complications of diabetes. Ann Intern Med 1984;101:82-91.
13. Terashima H, Hara K, Yamamoto R, et al. Effects of a new aldose reductase inhibitor on various tissues in vitro. J Pharmacol Exp Ther 1984;229:226-30.
14. Kern TS, Engerman RL. Distribution of aldose reductase in ocular tissues. Exp Eye Res 1981;33:175-82.
15. Fukushi S, Merola O, Tanaka M, Datiles M, Kinoshita JH. Reepithelialization of denuded corneas in diabetic rats. Exp Eye Res 1980;31:611-21.
16. Datiles MB, Kador PF, Fukui HN, Hu TS, Kinoshita JH. Corneal re-epithelialization ingalactosemic rats. Invest Ophthalmol Vis Sci 1983;24:563-9.
17. Hosotani H, Ohashi Y, Yamada M, Tsubota K. Reversal of abnormal epithelial cell morphology and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112. Am J Ophthalmol 1995;119:288-94.
18. Tsubota K, Toda I, Yagi Y, Ogawa Y, Ono M, Yoshino K. Three different types of dry eye syndrome. Cornea 1994;13:202-9.
19. Ogawa Y, Kamoshita I, Yoshino K, Ono M, Tsubota K. Dry eye in diabetes mellitus. Atarashii Ganka 1992;9:1867-70.
20. Paschides CA, Kitsios G. Evaluation of tear break-up time, Schirmer's 1 test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol 1989;7:155-7.
21. Sakamoto R, Bennet ES, Henry VA, et al. The phenol red thread tear test: a cross-cultural study. Invest Ophthalmol Vis Sci 1993;34:3510-14.
22. Cochet P, Bonnet R. L'esthesiometrie corneenne: realisation et interet pratique. Bull Soc Ophtalmol Fr 1961;61:541-50.
23. Toda I, Tsubota K. Practical double-vital staining for ocular surface evaluation. Cornea 1993;12:366-8.
24. Hotta N, Kakuta H, Ando F, Sakamoto N. Current progress in clinical trials of aldose reductase inhibitors in Japan. Exp Eye Res 1990;50:625-8.
25. Hotta N, Kakuta H, Ando F, Sakamoto N. Clinical trial of aldose reductase inhibitor ONO-2235: effect on diabetic retinopathy. In: Sakamoto N, Kinoshita JH, Kador PF, Hotta N, eds. Polyol pathway and its role in diabetic complications. Amsterdam: Excerpta Medica, 1988:253-66.
26. Hotta N, Kakuta H, Koh N, et al. In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor. Diabetes Res Clin Pract 1991;14:29-36.
27. Hotta N, Kakuta H, Fukasawa H, et al. Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats. Diabetologia 1985;28:176-80.
28. Ohashi Y, Matsuda M, Hosotani H, et al. Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy. Am J Ophthalmol 1988;105:233-8.
29. Jordan A, Baum J. Basic tear flow: does it exist? Ophthalmology 1980;87:920-30.
30. Gabbay KH, O'Sullivan JB. The sorbitol pathway: enzyme localization and content in normal and diabetic nerve and cord. Diabetes 1968;17:239-43.
31. Gilbard JP, Gray KL, Rossi SR. A proposed mechanism for increased tear-film osmolarity in contact lens wearers. Am J Ophthalmol 1986;102:505-7.
32. Schultz RO, Peters MA, Sobocinski K, Nassif K, Schultz KJ. Diabetic keratopathy as a manifestation of peripheral neuropathy. Am J Ophthalmol 1983;96:368-71.
33. John T, Rao GN, Aquavella JV. Corneal sensitivity in aphakic and pseudophakic eyes. CLAO J 1988;14:101-4.
34. Miyamoto S, Kajiwara I, Sawada M, et al. The distribution of ONO-2235 density in a living body after oral administration in rat. Gendai Iryo 1986;51:51-81.